Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
From Pre-Clinical Studies to First in Human: What's New on the Horizon
Tuesday August 05, 2025 - 16:30 to 17:45
Room: 12
34.7 Effects of Targeting the Cullin RING E3 Ubiquitin Ligase Using MLN4924 on the Alloimmune Response
Log in to add to favorites
Add Personal Notes
Bayan Alsairafi, United States
Presentations by Bayan Alsairafi
Tue-05 from 16:30 - 17:45 in room 12
From Pre-Clinical Studies to First in Human: What's New on the Horizon
Effects of Targeting the Cullin RING E3 Ubiquitin Ligase Using MLN4924 on the Alloimmune Response
Email:
info@wtc2025.org
514-874-1717
